Indomethacin inhibits the cellular receptor-dependent processing of low density lipoproteins; cyclic nucleotides have no effect.
D000328:Adult; D002478:Cells, Cultured; D004727:Endothelium / Q000378:metabolism; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000378:metabolism; D007213:Indomethacin / Q000494:pharmacology*; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008297:Male; D008469:Meclofenamic Acid / Q000494:pharmacology; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects* / Q000378:metabolism
D008077:Lipoproteins, LDL; D009712:Nucleotides, Cyclic; D011955:Receptors, Drug; D008469:Meclofenamic Acid; D007213:Indomethacin